9 results
Algorithm for the Evaluation and Management of Sickle Cell Crises
Clinical Manifestations and Management

#Diagnosis #Management #Hematology #SickleCell
Algorithm for the ... #Diagnosis #Management ... #Hematology #SickleCell ... Manifestations #Workup #Algorithm ... #Ddxof
Diagnosis and Management of Idiosyncratic Drug-induced Liver Injury (DILI)

DILI Types:
 • Intrinsic - predictable, dose dependent
Diagnosis and Management ... Idiosyncratic Drug-induced ... ongoing ↑ LFTs or symptoms ... #algorithm #gastroenterology ... #hepatology
Our approach to the diagnosis and initial management of patients with suspected HIT. Our approach is
management of patients ... #Diagnosis #Management ... #Hematology #HIT ... #Heparin #Induced ... Thrombocytopenia #Algorithm
Polycythemia Vera (PV) - Diagnosis and Management Summary
Diagnostic Criteria:
 • Elevated hemoglobin and/or hematocrit AND
 •
and Management ... Summary Diagnostic ... • Treatment algorithms ... #Management #Summary ... #treatment #hematology
Portopulmonary Hypertension
Presence of pulmonary arterial hypertension in a patient with portal hypertension
No other obvious causes (chronic
Transthoracic echocardiogram ... receptors, blocking the ... oxide through reduced ... vasodilation and reduced ... #management #hepatology
Algorithm regarding the diagnosis and treatment of Hereditary Hemochromatosis HH. 

Step 1: In the patient with
the diagnosis and ... suspected HH based on symptoms ... elevated iron indices ... #diagnosis #management ... #hepatology #gastroenterology
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
48% depending on the ... endothelial damage • Induce ... opacities • Diagnosis ... : >3 symptoms, or ... #management #hematology
Aplastic Anemia - Overview

Who?
• M = F
• 3 peaks:	1) Childhood	2) 15-25 years	3) >60 years

What?
• Aplastic anemia
that diminish the ... cells is much reduced ... symptoms that may ... Anemia #oncology #hematology ... #diagnosis #management
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
When present, symptoms ... • "Vasomotor" symptoms ... • Treatment algorithms ... #diagnosis #management ... #hematology